Literature DB >> 33403176

Functional Outcomes After Treatment of Posterior Inferior Cerebellar Artery Aneurysms.

Mostafa Fatehi1, Michael A Rizzuto1, Swetha Prakash1, Charles Haw1, Peter A Gooderham1, Gary J Redekop1.   

Abstract

Objective Aneurysms of the posterior inferior cerebellar artery (PICA) are a rare cause of subarachnoid hemorrhage. Treatment for this type of aneurysm may be microsurgical clipping or endovascular. This decision is based on patient characteristics, aneurysm location and dimensions, along with surgeon and institutional experience. In this study we aim to assess the outcomes of surgical and endovascular treatment of PICA aneurysms. Methods We retrospectively reviewed the charts of 52 patients who were admitted to Vancouver General Hospital for ruptured or symptomatic PICA aneurysms between 2005 and 2015. Modified Rankin scores were assigned at the time of discharge and at two subsequent follow-up time points. The mean short-term follow-up period post-operatively was 11.1 months and the mean long-term follow-up period was 19.3 months. Clinical and radiological characteristics were collected for all patients. Results Of the 52 patients, two died prior to obtaining treatment. Of the 50 patients who were treated for their PICA aneurysm, 39 presented with subarachnoid hemorrhage while 11 had symptomatic unruptured PICA aneurysms. Overall, 11 patients had endovascular treatment (coil embolization) while 39 patients underwent microsurgical clipping/trapping of the aneurysm. At the time of hospital discharge, patients in the microsurgical group trended towards a better the modified Rankin Scale score (2.3) compared to the endovascular group, though this did not reach significance (3.0) (p=0.20). The long-term score in the endovascular group (1.6) was also comparable to the microsurgical group (1.9) (p=0.55). Conclusion While the early outcomes in patients treated endovascularly appear better, there is no statistically significant difference in outcomes between the microsurgical and endovascular treatment groups at short- and long-term follow-up.
Copyright © 2020, Fatehi et al.

Entities:  

Keywords:  endovascular aneurysm repair; microsurgical aneurysm clipping; posterior inferior cerebellar artery; subarachnoid hemorrhage

Year:  2020        PMID: 33403176      PMCID: PMC7773522          DOI: 10.7759/cureus.11746

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

1.  Multimodality Treatment of Posterior Inferior Cerebellar Artery Aneurysms.

Authors:  Justin R Mascitelli; Kurt Yaeger; Daniel Wei; Christopher P Kellner; Thomas J Oxley; Reade A De Leacy; Johanna T Fifi; Aman B Patel; Thomas P Naidich; Joshua B Bederson; J Mocco
Journal:  World Neurosurg       Date:  2017-07-13       Impact factor: 2.104

2.  Distal posterior inferior cerebellar artery aneurysms: clinical features and management.

Authors:  Stephen B Lewis; Dongwoo John Chang; David A Peace; Pamela J Lafrentz; Arthur L Day
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

3.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

4.  Ruptured PICA aneurysms: presentation and treatment outcomes compared to other posterior circulation aneurysms. A Swiss SOS study.

Authors:  Daniele Starnoni; Rodolfo Maduri; Khalid Al Taha; David Bervini; Daniel Walter Zumofen; Martin Nikolaus Stienen; Bawarjan Schatlo; Christian Fung; Thomas Robert; Martin A Seule; Jan-Karl Burkhardt; Nicolai Maldaner; Michel Rothlisberger; Kristine A Blackham; Serge Marbacher; Donato D'Alonzo; Luca Remonda; Paolo Machi; Jan Gralla; Philippe Bijlenga; Guillaume Saliou; Pierluigi Ballabeni; Marc Levivier; Mahmoud Messerer; Roy Thomas Daniel
Journal:  Acta Neurochir (Wien)       Date:  2019-04-26       Impact factor: 2.216

5.  Clinical presentation and treatment of distal posterior inferior cerebellar artery aneurysms.

Authors:  Hiroshi Tokimura; Hitoshi Yamahata; Takashi Kamezawa; Kenichiro Tajitsu; Tetsuya Nagayama; Sei Sugata; Kosuke Takiguchi; Ayumi Taniguchi; Masaki Niiro; Kazuho Hirahara; Koji Takasaki; Tatsuki Oyoshi; Kazunori Arita
Journal:  Neurosurg Rev       Date:  2010-11-18       Impact factor: 3.042

6.  The Barrow Ruptured Aneurysm Trial: 6-year results.

Authors:  Robert F Spetzler; Cameron G McDougall; Joseph M Zabramski; Felipe C Albuquerque; Nancy K Hills; Jonathan J Russin; Shahram Partovi; Peter Nakaji; Robert C Wallace
Journal:  J Neurosurg       Date:  2015-06-26       Impact factor: 5.115

7.  Treatment and outcomes among 102 posterior inferior cerebellar artery aneurysms: a comparison of endovascular and microsurgical clip ligation.

Authors:  Bradley N Bohnstedt; Mary Ziemba-Davis; Gary Edwards; Jacqueline Brom; Troy D Payner; Thomas J Leipzig; John A Scott; Andrew J DeNardo; Erin Palmer; Aaron A Cohen-Gadol
Journal:  World Neurosurg       Date:  2014-12-23       Impact factor: 2.104

8.  Distal posterior inferior cerebellar artery aneurysms: clinical features and outcome of 80 patients.

Authors:  Hanna Lehto; Ali Harati; Mika Niemelä; Reza Dashti; Aki Laakso; Ahmed Elsharkawy; Jarno Satopää; Romain Billon-Grand; Bruno Canato; Riku Kivisaari; Juha Hernesniemi
Journal:  World Neurosurg       Date:  2014-06-14       Impact factor: 2.104

9.  Endovascular treatment of proximal and distal posterior inferior cerebellar artery aneurysms.

Authors:  Nohra Chalouhi; Pascal Jabbour; Robert M Starke; Stavropoula I Tjoumakaris; L Fernando Gonzalez; Samantha Witte; Robert H Rosenwasser; Aaron S Dumont
Journal:  J Neurosurg       Date:  2013-01-25       Impact factor: 5.115

10.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.